Hetrombopag for Pediatric Patients With Chronic Immune Thrombocytopenia
Clinical trial NCT04737850 · COMPLETED
Trial details
- NCT number
- NCT04737850
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-29
- Primary completion
- 2024-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.